Market Research Logo

Dermatology Drugs Market Global Briefing 2017Including: Dermatology DrugsCovering: Johnson & Johnson, Allergan Plc., Galderma S.A., Novartis AG, GlaxosmithKline Plc., Bayer AG, LEO Pharma A/S

Dermatology Drugs Market Global Briefing 2017Including: Dermatology DrugsCovering: Johnson & Johnson, Allergan Plc., Galderma S.A., Novartis AG, GlaxosmithKline Plc., Bayer AG, LEO Pharma A/S

The global dermatology drugs market is expected to reach over $35 billion in 2020. Going forward, increase in the number of indications treated by topical drugs coupled with increase in acne and rosacea patients will drive the market for dermatology drugs.

Dermatology Drugs Market Global Briefing provides strategists, marketers and senior management with the critical information they need to assess the global dermatology drugs sector.

Reasons to Purchase

  • Get up to date information available on the dermatology drugs market globally.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

Dermatology Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the dermatology drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the dermatology drugs market and suggests approaches.

Scope

Markets Covered: Dermatology Drugs
Companies Mentioned: Johnson & Johnson, Allergan Plc., Galderma S.A., Novartis AG, GlaxosmithKline Plc., Bayer AG, LEO Pharma A/S
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


Dermatology Drugs Market Characteristics
Dermatology Drugs Market Historic Growth
Dermatology Drugs Market Forecast Growth
Dermatology Drugs Market Geography Regional and Country Comparison
Global Dermatology Drugs Market, Split By Regions, 2016
Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Global Dermatology Drugs Market, Split By Country, 2016
Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Dermatology Drugs Market Competitive Landscape
Johnson & Johnson
Galderma S.A.
Allergan Plc.
Novartis AG
GlaxosmithKline Plc.
Bayer AG
LEO Pharma A/S
Johnson & Johnson (J&J)
Allergan
Galderma S.A.
Dermatology Drugs Market Key Mergers And Acquisitions
Nestle Acquired Galderma
L'Oreal Acquired Valeant Pharmaceutical’s Dermatology Brands
LEO Pharma Acquired Astellas’ Dermatology Portfolio
Allergan Acquired Vitae Pharmaceuticals
Valeant Pharmaceuticals Acquire PreCision Dermatology, Inc.
Novartis Acquired Ziarco Group Limited
Zydus Acquired Issar Pharmas Melgain
Allergan Acquires Anterios
Dermatology Drugs Market Trends And Strategies
Immune Modulators To Treat Eczema
Genome Testing To Speed Clinical Trials Of Drugs
Increase In Mergers And Acquisitions Activity
Early Rx-To-OTC Switch
Biologics For Dermatology
Appendix
NAICS Definitions Of Industry Covered In This Report
Definition Of Market Covered In This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
The Business Research Company
List of Figures
Figure 1: Global Dermatology Drugs Market, Historic Market Size, 2012-2016, $ Billion
Figure 2: Global Dermatology Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Figure 3: Global Dermatology Drugs Market, Split By Region, 2016, $ Billion
Figure 4: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Figure 5: Global Dermatology Drugs Market, Split By Country, 2016, $ Billion
Figure 6: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Figure 7: Global Dermatology Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)
List of Tables
Table 1: Global Dermatology Drugs Market, Historic Market Size, 2012-2016, $ Billion
Table 2: Global Dermatology Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion
Table 3: Global Dermatology Drugs Market, Split By Region, 2016, $ Billion
Table 4: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020
Table 5: Global Dermatology Drugs Market, Split By Country, 2016, $ Billion
Table 6: Global Dermatology Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020
Table 7: Global Dermatology Drugs Market, Key Competitor Market Shares, 2016, Percentage (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report